Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy

Mucopolysaccharidosis type II (MPSII) is a pediatric lysosomal storage disease caused by deficiencies in the IDS (iduronate-2-sulfatase) gene resulting in accumulation of glycosaminoglycans, multisystem disease, and profound neurodegeneration in severe forms. Although enzyme replacement therapy is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellison, Stuart, Liao, Aiyin, Gleitz, Hélène F.E., Parker, Helen, Booth, Laura, Robinson, John, Wood, Shaun, Taylor, Jessica, Holley, Rebecca, Bigger, Brian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618237/
https://www.ncbi.nlm.nih.gov/pubmed/37920237
http://dx.doi.org/10.1016/j.omtm.2023.101127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618237/
https://www.ncbi.nlm.nih.gov/pubmed/37920237
http://dx.doi.org/10.1016/j.omtm.2023.101127

Ejemplares similares